Zacks Investment Research lowered shares of MedEquities Realty Trust (NYSE:MRT) from a buy rating to a hold rating in a research report sent to investors on Wednesday, January 3rd.

According to Zacks, “MedEquities Realty Trust, Inc. owns, develops, operates, leases and disposes healthcare properties and portfolios. It operates primarily in Texas, California, Nevada and South Carolina. MedEquities Realty Trust, Inc. is based in Nashville, Tennessee. “

How to Become a New Pot Stock Millionaire

Several other equities analysts have also recently weighed in on MRT. KeyCorp reiterated a buy rating and issued a $13.00 price objective on shares of MedEquities Realty Trust in a research note on Tuesday, September 26th. Capital One Financial assumed coverage on shares of MedEquities Realty Trust in a research note on Monday, October 23rd. They issued an equal weight rating and a $13.00 price objective on the stock. B. Riley restated a buy rating on shares of MedEquities Realty Trust in a research note on Wednesday, November 1st. Finally, ValuEngine upgraded shares of MedEquities Realty Trust from a hold rating to a buy rating in a research note on Friday, December 1st. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. MedEquities Realty Trust currently has an average rating of Buy and an average target price of $13.00.

MedEquities Realty Trust (NYSE MRT) traded up $0.04 on Wednesday, reaching $10.91. 15,294 shares of the company’s stock traded hands, compared to its average volume of 151,816. MedEquities Realty Trust has a 1-year low of $10.06 and a 1-year high of $13.06. The company has a market cap of $352.49, a PE ratio of 27.18 and a beta of -0.74.

MedEquities Realty Trust (NYSE:MRT) last issued its quarterly earnings data on Tuesday, November 7th. The financial services provider reported $0.17 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.30 by ($0.13). MedEquities Realty Trust had a return on equity of 5.88% and a net margin of 35.61%. The business had revenue of $15.77 million during the quarter, compared to the consensus estimate of $15.49 million. sell-side analysts anticipate that MedEquities Realty Trust will post 1.12 earnings per share for the current year.

In related news, Director Randy L. Churchey acquired 5,300 shares of the business’s stock in a transaction on Monday, November 20th. The stock was acquired at an average cost of $10.87 per share, with a total value of $57,611.00. Following the acquisition, the director now directly owns 46,776 shares in the company, valued at approximately $508,455.12. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO John W. Mcroberts acquired 18,000 shares of the business’s stock in a transaction on Friday, November 17th. The shares were bought at an average cost of $10.74 per share, with a total value of $193,320.00. The disclosure for this purchase can be found here. In the last 90 days, insiders have acquired 23,600 shares of company stock worth $254,129. 2.50% of the stock is owned by company insiders.

A number of institutional investors and hedge funds have recently made changes to their positions in MRT. Wells Fargo & Company MN grew its holdings in shares of MedEquities Realty Trust by 2.0% in the second quarter. Wells Fargo & Company MN now owns 24,666 shares of the financial services provider’s stock valued at $311,000 after purchasing an additional 482 shares in the last quarter. Parametric Portfolio Associates LLC boosted its stake in MedEquities Realty Trust by 4.4% during the second quarter. Parametric Portfolio Associates LLC now owns 40,531 shares of the financial services provider’s stock worth $512,000 after buying an additional 1,704 shares during the period. Dynamic Technology Lab Private Ltd boosted its stake in MedEquities Realty Trust by 25.1% during the second quarter. Dynamic Technology Lab Private Ltd now owns 16,686 shares of the financial services provider’s stock worth $210,000 after buying an additional 3,346 shares during the period. IndexIQ Advisors LLC boosted its stake in MedEquities Realty Trust by 11.7% during the second quarter. IndexIQ Advisors LLC now owns 32,620 shares of the financial services provider’s stock worth $412,000 after buying an additional 3,410 shares during the period. Finally, Nationwide Fund Advisors boosted its stake in MedEquities Realty Trust by 48.0% during the second quarter. Nationwide Fund Advisors now owns 17,849 shares of the financial services provider’s stock worth $225,000 after buying an additional 5,791 shares during the period. 93.21% of the stock is owned by institutional investors and hedge funds.

TRADEMARK VIOLATION WARNING: This story was posted by Marea Informative and is the sole property of of Marea Informative. If you are viewing this story on another site, it was illegally copied and reposted in violation of international copyright laws. The original version of this story can be viewed at https://www.mareainformativa.com/2018/01/30/zacks-investment-research-lowers-medequities-realty-trust-mrt-to-hold-updated-updated-updated.html.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.

Get a free copy of the Zacks research report on MedEquities Realty Trust (MRT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.